SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-043582
Filing Date
2023-12-04
Accepted
2023-12-04 17:00:11
Documents
13
Period of Report
2023-12-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36032
2 ex99-1.htm EX-99.1 9807
  Complete submission text file 0001493152-23-043582.txt   221707

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gtbp-20231204.xsd EX-101.SCH 3024
4 XBRL LABEL FILE gtbp-20231204_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE gtbp-20231204_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3303
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40023 | Film No.: 231464071
SIC: 2834 Pharmaceutical Preparations